https://www.selleckchem.com/pr....oducts/ag-1024-tyrph
going MPCNL had a lower post-operative pain rate and a faster recovery. Compared to adult studies, studies which involve the treatment of pediatric congenital hypogonadotropic hypogonadism (CHH) are limited and no universal treatment regimen is available. The aim of this study was to evaluate the feasibility of human chorionic gonadotropin (hCG)/human menopausal gonadotropin (hMG) therapy for treating male adolescents with CHH. Male adolescent CHH patients were treated with hCG/hMG (n = 2 or a gonadotropin-releasing hormone
Like
Comment
Share
